SCHEMBL6481322

SCHEMBL6481322

Cn1c(CF)nc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.63
RAB9A P51151 11/20 0.63
SMN1; SMN2 Q16637 7/20 0.63
KDM4E B2RXH2 1/20 0.63
LMNA P02545 3/20 0.60
POLB P06746 1/20 0.58
TP53 P04637 2/20 0.58
ALDH1A1 P00352 1/20 0.58
ALOX15 P16050 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAPT P10636 2/20 0.57
PKM P14618 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPK1 P28482 1/20 0.56
GFER P55789 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1059693 0.84 RAB9A (0.64) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL3397691 0.84 RAB9A (0.55) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL30037937 0.82 RAB9A (0.62) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL757031 0.82 RAB9A (0.62) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL285358 0.81 RAB9A (0.60) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL103809 0.81 RAB9A (0.60) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL243922 0.81 LMNA (0.61) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL2929122 0.81 MAPT (0.66) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL104281 0.81 HDAC6 (0.61) NPC1RAB9ASMN1; SMN2KDM4ELMNA
SCHEMBL14050118 0.81 MAPT (0.76) NPC1RAB9ASMN1; SMN2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011025774-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2011-03-03 WO disclosed
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed